Table 1.
Reference values | 2012 | 2013 | 2014 | 2015 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
June | March | September | February | 3rd June | 6th June * | August | October | January | April | July † | ||
TSH (mU/l) | 0.6–6.4 μU/l | 0.11 | 1.1 | 0.026 | 0.027 | 46 | 14.2 | 0.018 | 0.016 | 1.21 | 0.008 | <0.004 |
T4 (ng/dl) | 0.8–1.99 | 1.99 | 1.054 | 1.5 | 1.3 | 0.5 | 0.6 | 2.8 | 2.1 | 1.0 | 1.9 | 3.1 |
T3 (pg/ml) | 1.4–4.4 | – | – | – | – | – | 3.5 | 11.0 | 6.4 | – | 5.8 | – |
TPO Abs (UI/ml) | < 35 | 496.2 | 7786.5 | 10848.7 | 6235.5 | – | >1000 | >1000 | >1000 | – | – | 948 |
TRAbs (UI/l) | <14 | – | – | – | 4.1 | 10.8 | – | – | – | 32.9 | – | 20 |
Levothyroxine (μg/kg per day) | – | – | 0.37 | 0.18 | – | – | 0.73 | 0.73 | 0.73 | 0.73 | 0.73 | 0.37 |
Methimazole (mg/kg per day) | – | – | – | – | – | – | – | 0.15 | 0.20 | 0.20 | 0.20 | 0.23 |
Scintigraphic findings of homogeneously increased iodine uptake, suggestive of Graves' disease.
Serum sample where bioassay to estimate TSAbs and TBAbs biological activity was performed.